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Available online 6 June 2016The measurement of the absolute rate of cerebral metabolic oxygen consumption (CMRO2) is likely to offer a
valuable biomarker in many brain diseases and could prove to be important in our understanding of neural
function. As such there is signiﬁcant interest in developing robust MRI techniques that can quantify CMRO2
non-invasively. One potential MRI method for the measurement of CMRO2 is via the combination of fMRI and
cerebral blood ﬂow (CBF) data acquired during periods of hypercapnic and hyperoxic challenges. This method
is based on the combination of two, previously independent, signal calibration techniques. As such analysis of
the data has been approached in a stepwise manner, feeding the results of one calibration experiment into the
next. Analysing the data in this manner can result in unstable estimates of the output parameter (CMRO2), due
to the propagation of errors along the analysis pipeline. Here we present a forward modelling approach that
estimates all the model parameters in a one-step solution. The method is implemented using a regularized
non-linear least squares approach to provide a robust and computationally efﬁcient solution. The proposed
framework is compared with previous analytical approaches using modelling studies and in vivo acquisitions
in healthy volunteers (n= 10). The stability of parameter estimates is demonstrated to be superior to previous
methods (both in vivo and in simulation). In vivo estimatesmadewith the proposed framework also show better
agreement with expected physiological variation, demonstrating a strong negative correlation between baseline
CBF and oxygen extraction fraction. It is anticipated that the proposed analysis framework will increase the
reliability of absolute CMRO2 measurements made with calibrated BOLD.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
The rate of metabolic oxygen consumption in the brain (CMRO2) is a
valuable biomarker in the assessment of disease and treatment effect
(Heiss and Herholz, 1994; Lammertsma, 1987; Tohgi et al., 1998).
Clinical studies using oxygen-15 PET have shown altered oxygen
metabolism in a variety of diseases and disorders (Broich et al., 1992;
Silverman andAlavi, 2005). However, such examinations cannot be rou-
tinely undertaken due to the lack of availability and the risks associated
with the repeated administration of ionising radiation. Thus, there is
signiﬁcant interest in the development of alternative methods that can
be more routinely employed to map CMRO2. One such emerging
technique is through the calibrated measurement of the MRI blood
oxygenation level dependent (BOLD) signal (Bulte et al., 2012;
Gauthier et al., 2012; Germuska and Bulte, 2014; Wise et al., 2013).
This approach, which we shall refer to as dual-calibrated functional
MRI (dcfMRI), is based on the quantiﬁcation of cerebral bloodInc. This is an open access article uﬂow (CBF) and the change in venous oxygenation during periods of
respiratory challenge.
The dcfMRI method requires at least two independent probes of
the cerebral vasculature. Typically, hypercapnic and hyperoxic gas
challenges are used, with hypercapnia producing an increase in CBF
and hyperoxia directly modulating the venous oxy-haemoglobin
saturation. In order to estimate the resting CMRO2 a physiological
model is used to analyse the CBF and BOLD responses to the stimuli. In
previous implementations of this method the CBF and BOLD data have
been analysed independently, creating intermediate variables that are
then fed into a physiological model to solve for the resting oxygen
extraction fraction (OEF), and thus for CMRO2. Approaching the
problem in this stepwise manner can create an unstable solution due
to the propagation of errors along the analysis pipeline. In fact solutions
for OEF often do not exist with this approach due to incompatible
estimates of CBF and BOLD signal changes (Gauthier et al., 2012). An
alternative approach is to use numerical methods to simultaneously
estimate all MR and physiological parameters in a one-step solution.
In practice this can be achieved by ﬁnding the parameter set that
minimises the error between a forward model and the acquired
MR data. In this approach the CBF and BOLD signals are estimatednder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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CBF signal used to infer on the BOLD signal and vice versa. Therefore
this approach takes greater advantage of the available data, by combin-
ing the CBF and BOLD information. Thus, the proposed method is
expected to improve upon the accuracy and repeatability of dcfMRI.
In addition, all parameter estimates made with this approach can be
guaranteed to exist by restricting the search space of the forwardmodel.
In the work presented here the optimisation problem is posed as a
non-linear least squares problem with L2 parameter regularization.
Because the newmethod estimates all parameters simultaneously it be-
comes possible to factor out OEF from the BOLD calibration parameter
(M). In addition, the forward model is made more general by replacing
the fractional change in CBFwith the relative cerebral vascular reactivity
(CVR). These substitutions mean that the effect of regularization is not
dependent on the stimulus or experimental design. Investigation of
the forward model also demonstrates how the resting venous cerebral
blood volume (CBV) can be estimated from the BOLD calibration
parameter and the resting OEF.
Simulations using standard noise modelling techniques are
performed for a cross-validation study to optimise the regularizationFig. 1. Schematic overview of the key piecestuning parameter (λ) and subsequently for a comparison with
existing analysis methods (Bulte et al., 2012; Gauthier et al., 2012).
The tuning parameter is optimised over a wide range of baseline
physiological states to minimise the bias associated with regulariza-
tion. In addition to simulation studies, a comparison against existing
analysis methods is made using in vivo data (acquired in 10 healthy
volunteers).
The presentation of work in this manuscript is separated
into three main sections: simulation and associated optimization of
the proposed technique, a comparison of the proposed method
with existing methods via simulation, and an in vivo comparison
in healthy volunteers. Fig. 1 gives a schematic overview of the
workﬂow for reference.
Methods
Forward signal model
As per (Woolrich et al., 2006) the MR signal model used here
describes the total signal (blood and static tissue). The model consistsof work presented in this manuscript.
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a BOLD component (contained within ΔR2⁎) as described by Eq. (1).
pn ¼ Sn∙e−TE∙R

2;0 1þΔR2;n=R2;0ð Þ ð1Þ
where pn is the MR signal for n=1 to N acquisitions, Sn is the magneti-
zation in a voxel, R2⁎ , 0 is the baseline R2⁎, ΔR2,n⁎ is the change in R2⁎ for
each acquisition, and TE is the echo time.
As shown inAppendix A, pn can be estimated froma set of physiolog-
ical parameters, end-tidal respiratory recordings, an ASL signal model,
and a generalised BOLD calibration model. For a dual-echo ASL
sequence, which is increasingly being acquired in calibrated fMRI
experiments (Germuska and Bulte, 2014; Wise et al., 2013), the
acquired data can be expressed as shown by Eq. (2).
Y ¼ p1;n;p2;n
 þ e1;n; e2;n  ¼ g θ; tracesð Þ þ e ð2Þ
where Y is the measured data, g is the multi-echo signal model, e is ad-
ditive noise, θ is the set of physiologicalmodel parameters (see Table 1),
and traces consist of PETO2 and ΔPETCO2 (measured in mm Hg).
Compared to previous implementations of dcfMRI, the calibration
parameter is renamed (K), as it no longer includes contributions from
OEF. Additionally, CVR is used as a replacement for fractional ﬂow
change using the empirical observation that ΔPaCO2 is linearly related
to ΔCBF for moderate changes in PaCO2 (as caused by hypercapnic gas
challenges) (Reivich, 1964; Tancredi and Hoge, 2013).
The forward model is solved using a regularized non-linear least
squares ﬁt to the acquired data, using a tuning parameter λ to
determine the strength of the regularization (see Eq. (3).
min
θ
g θ; tracesð Þ− Yk k22 þ λ2 θ1−3k k22
 
ð3Þ
The regularization is only applied for the ﬁrst three parameters
(K, OEF0 and CVR), as these are the main drivers of any instability in
the ﬁtting. Because each parameter is centred and scaled prior to ﬁtting,
the relative strength of regularization is determined by our expectation
of the biological variance of each parameter. To estimate the biological
variancewe have assumed a uniform distribution bounded by plausible
in vivo values. Thus K (which is determined by the resting CBV) is
assumed to lie between 0 and 0.3, OEF0 is expected to lie between 0.1
and 0.7, and CVR is assumed to have a value between 1% and 6%
ΔCBF/mm Hg.
Compared to previous analysis approaches the forward model esti-
mates one additional parameter. Using a standard analytical approach
to calculate CMRO2, estimates would need to be made of the BOLD sig-
nal changes due to O2 and CO2, the calibration factor M, the change in
blood ﬂow due to CO2, and the resting blood ﬂow. The extra parameter
estimated in the forward model allows the CBF contribution to TE2
(or any additional echoes) to be included into the analysis rather than
averaged out (as is normal practice). The end-tidal traces (PETO2 and
PETCO2) are used to constrain the ﬁtting to the experimental paradigm.
In addition, PETO2 is used to estimate the arterial change in blood T1 as
described in Appendix A.Table 1
Summary of the physiological parameters used in the forward signal model.
Model parameters, θ Description
K BOLD calibration parameter
OEF0 Baseline oxygen extraction fraction
CVR Relative ﬂow cerebrovascular reactivity to carbon dioxide
CBF0 Baseline cerebral blood ﬂow
M0 Baseline static magnetisation per voxel
R2,0⁎ Baseline transverse relaxation rateModelling studies
The proposed analysis method, and previous analysis methods
(Bulte et al., 2012; Gauthier et al., 2012), were investigated with a
noise modelling study. All data were generated using MATLAB,
with the analysis being performed using a combination of MATLAB
and FSL scripts.
Simulated datawere generated using thedescribed ASL signalmodel
and a multi-compartmental BOLD model (Griffeth and Buxton, 2011).
The multi-compartmental BOLD model extends that used for the
analysis by explicitly considering contributions from extravascular and
intravascular compartments for arterial, venous and capillary blood.
Whereas, the BOLD model used for analysis groups all of these effects
into three summary parameters (α, β and K). As such, the compartmen-
talmodel is expected to be amore accurate description of thephysiolog-
ical dependences of the BOLD signal and therefore is utilised for data
generation in this study.
Additive noise was modelled with an explicit physiological noise
model (Kruger and Glover, 2001), which includes contributions from
thermal white noise (σ0), non-BOLD physiological noise (σNB), and
BOLD-like physiological noise (σB). The Gaussian noise variances were
modelled for 3.0 T as per Kruger et al., with σNB = 0.21 and σB = 0.51
(TE = 29 ms) and σB = 0.05 (TE = 2.7 ms). The voxel size was set
to 3.4 × 3.4 × 7 mm, with a 6 mm 3D Gaussian smoothing kernel,
producing σ0 = 0.10. In addition, temporal correlations, using an
autoregressive process, and low frequency drifts were included. The
temporal AR(1) coefﬁcient was set to 0.23 for the ﬁrst echo and 0.55
for the second echo (Woolrich et al., 2006). Low frequency baseline
drifts were estimated by ﬁtting a 4th order polynomial to historic
resting-state data acquired with a dual-echo PASL sequence with echo
times of 2.7 ms and 29 ms (matching those used in the simulation).
Because the acquired resting-state data was only 12 min in duration,
interpolation in the frequency domain was used to artiﬁcially extend
the data to the required time (18 min).
The simulated gas paradigm (see Fig. 2) was designed to match the
end-tidal traces recorded in vivo. The simulated paradigm was 18 minFig. 2. Simulated gas paradigm with interaction terms. Top: PaO2 (mm Hg). Bottom:
change in PaCO2 (mm Hg).
Fig. 4. Boxplot showing the error between the simulated and estimated OEF0 for each
analysis method. A. Forward model. B. Forward model with regularisation. C. Bulte
analytical method. D. Gauthier analytical method. The forward modelling method with
regularisation demonstrates the least bias and smallest error. The Bulte and Gauthier
analytical methods demonstrate similar levels of uncertainty. There is a signiﬁcant
difference (p b 0.05) in the spread of OEF0 estimates between each method, apart from
the two analytical approaches (p=0.06). A Student's t-test of themeans shows no signif-
icant difference between the forward model with or without regularisation (p= 0.785).
However, each of the other methods has signiﬁcantly different means (p b 0.05).
Table 2
Parameter values and ranges used in the simulation studies.
Parameter Value Parameter Value
TI1 0.7 s α venous 0.2
TI2 1.5 s α arterial 0.38
TE1 2.7 ms CVR 1 to 6% ΔCBF/mm Hg
TE2 29 ms δt 0.4 s
Venous blood volume fraction 0.4 CBV total 0.01 to 0.1%
Arterial blood volume fraction 0.2 OEF0 0.1 to 0.6
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terleaved around baseline/resting periods. For each hypercapnic period
ΔPaCO2 was set to 11 mmHg and for each hyperoxic period ΔPaO2 was
set to be 240 mm Hg (values chosen to match in vivo recordings).
During periods of hypercapnia a 24-mm Hg increase was included in
PaO2, while during hyperoxia a 2-mm Hg reduction in PaCO2 was
included. These interaction terms are based on the observed in vivo
changes and it is assumed that the reduction in PaCO2 during hyperoxia
is responsible for any ﬂow changes during these periods (i.e. there is no
separate effect of hyperoxia on ﬂow included in the modelling).
The simulated T1 of arterial blood was set to match that used in the
forward model (see Appendix A). A gamma-variate function (Madsen,
1992) was convolved with the generated block gas designs to account
for the dispersion in the arterial stimulus. The tmax and dispersion
parameters of the gamma-variate were found from recordings of end-
tidal CO2 and O2 during in vivo scanning, and were set to tmax = 25 s
and dispersion = 0.5 for both the CO2 and O2 stimuli. While arterial
changes in CO2 are generally quicker than changes in O2, in our imple-
mentationO2 stimuli are initiatedwith a period of 100%O2 and followed
up with a period of inspiratory hypoxia to ensure fast transitions. Thus,
a similar transition time was found for both stimuli.
Simulations were undertaken to optimise the tuning parameter λ
used in the forward modelling approach. One thousand time-courses
were simulated with a set of randomly sampled physiological values
for each simulation. The simulations were repeated with values of λ
ranging from 0.25 to 5. The physiological values were sampled from a
wide range to encapsulate potential in vivo variation both in healthy
and diseased tissue (see Table 2 for a summary).
The simulated data was analysed with the forward model to ﬁnd
the optimal value of λ. The root mean squared error between the
estimated and simulated OEF0 for each value of λ was used to pick the
optimal value.
The same simulated data was used to compare the performance of
the forward model (with optimised λ) to the analytical methods
proposed by Bulte et al. and Gauthier et al. (Bulte et al., 2012;
Gauthier et al., 2012). For the analytical methods the simulated dataFig. 3. RMS error in estimated OEF0 vs. simulated OEF0 for the forward modelling analysis
method plotted against the value of the regularisation tuning parameter λ. The optimal
value of λ (minimum error) is close to 1.was processed using FEAT (Jenkinson et al., 2012) to make estimates
of ΔCBF|CO2 and ΔBOLD|CO2 and ΔBOLD|O2. The change in blood ﬂow
and BOLD signals was analysed using a GLM ﬁt to the data as per
(Gauthier et al., 2012). However, rather than discarding the transition
data (between baseline and the stimulus steady state) regressors were
convolved with a gamma-variate function as per (Bulte et al., 2012).
This was done to allow the best match between the forward model
and the analytical approaches, both using all the time course dataFig. 5. Example end-tidal gas recordings from an individual subject. Top: End-tidal oxygen
recordings. Bottom: End-tidal carbon dioxide recordings. The rise and fall times for both
stimuli appear to be similar. Periods of elevated PETCO2 produce a corresponding
increase in PETO2, while periods of elevated PETO2 appear to produce a reduction in PETCO2.
Table 3
Average (median) grey matter parameter estimates for each subject assessed using the
proposed forward modelling analysis method.
Subject OEF0 CBF0
ml/100 g/min
CBV0
%
CVR
%ΔCBF/mm Hg
CMRO2
μmol/100 g/min
1 0.40 58.69 2.44 2.15 186.4
2 0.40 57.96 2.94 2.01 181.0
3 0.35 72.06 2.74 3.14 202.5
4 0.39 68.67 2.25 2.59 213.0
5 0.34 95.25 2.14 2.36 258.5
6 0.39 58.35 2.21 2.97 179.1
7 0.46 44.76 2.12 3.13 160.2
8 0.41 64.59 1.73 3.40 212.9
9 0.37 88.60 2.04 3.50 269.9
10 0.40 44.47 1.94 3.46 141.5
Mean ±
SD
0.39 ±
0.03
65.3 ±
16.6
2.25 ±
0.36
2.87 ±
0.56
200.5 ±
40.3
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model, oxygen and carbon dioxide are assumed to be isometabolic.
However, a CBF reduction during O2 was included separately from the
model ﬁts as per (Gauthier et al., 2012). A 2.4% reduction in ﬂow was
used, assuming a linear scaling of the ﬂow reduction with the change
in end-tidal O2. OEF estimates for the Bultemethod were calculated by
ﬁrst calculating the CO2 M value and then feeding this into the O2 cali-
bration equation, while the OEF for the Gauthiermethod was calculated
using a bisection ﬁtting method to ﬁnd the values of M and OEF that ﬁt
the estimated CO2 and O2 signal changes (Bulte et al., 2012; Gauthier
et al., 2012).
In vivo scanning (gas delivery)
In vivo data were acquired from a cohort of 10 healthy volunteers
(6 male and 4 female, mean age 27.4 ± 10 years) with each subject
having given informed written consent. Experimental procedures
were approved by the local institutional ethical review committee.
Respiratory challenges were administered using a previously described
dynamic end-tidal forcing system (Wise et al., 2007). However, the
feedback mechanism was disabled, producing an automated delivery
system for ﬁxed inspired fractions rather than targeting end-tidal
values. Gas delivery was controlled by four mass ﬂow controllers
(MKS Instruments, Wilmington, MA, USA). Tidal gases, sampled from
the volunteer's facemask and PETCO2 and PETO2, were measured using
rapidly responding gas analysers (AEI Technologies, Pittsburgh, PA,
USA). The gas mixtures were delivered at a total ﬂow rate of 25 l per
minute (lpm) through a fast gas mixing chamber connected to a tight-
ﬁtting facemask worn by the volunteer (Quadralite, Intersurgical,
Wokingham, Berkshire, UK). The facemask was connected by a series
of one-way valves to a reservoir limb (as described by Tancredi et al.Fig. 7. Scatter plots of resting CBF against resting OEF as estimated by each of the
implemented analysis methods. There is a strong negative correlation between the
resting CBF and OEF when the in vivo data is analysed with the forward model. No such
relationship is found when analysing the data with the analytical approaches of Bulte
and Gauthier.
Fig. 6.Example voxel-wiseﬁt of in vivo data. Top: Processed TE1 data (blue) andﬁt (black).
Bottom: TE2 data (blue) and ﬁt (black). Both the acquired and estimated TE2 data have
been high-pass ﬁltered (300 s cut-off) to reduce the inﬂuence of baseline drift.
Table 4
Average (median) greymatter parameter estimates and the coefﬁcient of variation (COV)
of OEF0 estimates for each subject and analysis method (forward modelling with L2
regularisation and the two analytical approaches proposed by Bulte and Gauthier).
Subject OEF0
FWD L2
COV(OEF0)
FWD L2
OEF0
Bulte
COV(OEF0)
Bulte
OEF0
Gauthier
COV(OEF0)
Gauthier
1 0.40 0.33 0.19 0.57 0.19 0.66
2 0.40 0.34 0.16 0.70 0.16 0.70
3 0.35 0.32 0.26 0.70 0.26 0.70
4 0.39 0.33 0.33 0.62 0.32 0.64
5 0.34 0.39 0.25 0.69 0.21 0.72
6 0.39 0.35 0.34 0.51 0.33 0.54
7 0.46 0.38 0.21 0.80 0.20 0.82
8 0.41 0.34 0.32 0.60 0.34 0.62
9 0.37 0.33 0.29 0.59 0.30 0.61
10 0.40 0.35 0.24 0.73 0.25 0.73
Mean ±
SD
0.39 ±
0.03
0.35 ±
0.02
0.26 ±
0.06
0.65 ±
0.09
0.25 ±
0.06
0.67 ±
0.09
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inspiratory rate exceeded 25 lpm.
The respiratory paradigmmatched the design used in the simulation
studies (Fig. 2). The design is 18 min in length and consists of 3 periods
of hypercapnia interleaved with 2 periods of hyperoxia. Each period of
hyperoxia was initiated with a short duration (14 s) of 100% oxygen,
which acts as a pre-emphasis to shorten the transition from baseline
to stable hyperoxia. At the end of each hyperoxic block a hypoxic gas
mixture (10% O2, 90% N2) is delivered for (40 s) to ensure a rapid
transition back to baseline. Inspired fractions of 5% CO2 and 50% O2
with balanced air were delivered during plateau periods.
In vivo scanning (MRI acquisitions)
Image data were acquired on a 3 T whole body MRI system (GE
Excite HDx, Milwaukee, WI) using an eight-channel receive-only
head coil. Functional data were acquired using a pulsed arterial spin
labelling (ASL) proximal inversion and control for off-resonance effects
(PICORE), quantitative imaging of perfusion using a single subtraction
(PICORE QUIPSS II) (Wong et al., 1998) imaging sequence. This
sequence used a dual-echo gradient echo (GRE) readout and spiral
k-space acquisition (Glover, 1999) (TE1 = 2.7 ms TE2 = 29 ms, TR =
2.2 s, ﬂip angle 90°, FOV 22 cm, matrix 64 × 64, 12 slices of 7 mm
thickness with an inter-slice gap of 1 mm, TI1 = 700 ms, TI2 =
1500 ms for the most proximal slice, 10 cm inversion slab thickness,Fig. 8. In vivomaps of OEF for a single subject (four slices). The top four slices are calculated usi
proposed by Gauthier et al. The maps generated with the forward model are more uniform wiadiabatic hyperbolic secant inversion pulse, 10 mm gap between
labelling slab and bottom slice, 10 cm QUIPSS II saturation band
thickness). Two scans were performed in each session with 490
repetitions (image volumes) collected in each scan. A separate single
shot (M0) scan was acquired with the same parameters as the function-
al runs to measure the equilibrium brain tissue magnetisation for
purposes of calculating CBF0. A whole brain T1-weighted structural scan
(fast spoiled gradient recalled echo, 1 × 1 × 1 mm voxels, TI/TR/TE =
450/7.8/3 ms) was acquired to facilitate segmentation of the grey matter
and CSF.
Data analysis
To enable quantiﬁcation of CBF0 the signal from CSF was measured
from the fully relaxed scan to estimate the M0 of blood. Calculation of
all physiological parameters was performed to match the pipeline
used for analysing the simulated data (for both the forward modelling
approach and the two analytical methods). Thus, spatial smoothing
using a 6 mm FWHM Gaussian low-pass ﬁlter was applied to all data
and a high-pass ﬁlter was applied to TE2 data. When using the forward
modelling approach TE1 data was high pass ﬁltered using surround
subtraction (see Appendix A for more details).
Anatomical T1-weighted images were registered to the fMRI data
using the FSL program FLIRT (Jenkinson and Smith, 2001). Partial
volume estimates of grey matter (greater than 50%) (FAST image seg-
mentation) were used to generate grey matter parameter estimates.
The code used in this manuscript is openly available from the Cardiff
University data archive http://dx.doi.org/10.17035/d.2015.100126.
However, due to ethical considerations open access cannot be given to
the in vivo subject data or data derived from this.
Statistical analysis of the results was performed using Matlab.
Statistical tests include regression analysis, t-tests and Westenberg
scale test (Westenberg, 1948) for interquartile range equality. In
all cases a signiﬁcance level of p = 0.05 was used as a threshold to
determine statistical signiﬁcance.
Results
Modelling results
The noisemodelling simulations demonstrated that a tuning param-
eter (λ) close to 1 produced the smallest RMS error in OEF0 estimatesng the forward modelling method; the bottom four slices are calculated using themethod
th signiﬁcantly fewer regions with non-physiological estimates.
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all subsequent modelling and data analysis.
The performance of the forward model was compared to analytical
analysis of the data as per (Bulte et al., 2012; Gauthier et al., 2012) in
both simulated and in vivo data. The simulated results demonstrate a
signiﬁcant reduction in uncertainty when using the forward model.
Fig. 4 shows boxplots of the error in estimated simulated OEF0 values
for each of the three methods (the performance of the forward model-
ling approach is displayed with and without regularisation). The inter-
quartile ranges (IQR) of the error in OEF0 estimates were 0.15, 0.11,
0.18, and 0.17 for the forward model (without regularisation), the for-
ward model (with L2 regularisation), the analytical approach proposed
by Bulte et al. and the analytical approach proposed by Gauthier et al.
The IQR of modelled OEF0 estimates is signiﬁcantly reduced when
using the regularised forward modelling method (p b 0.05), as assessed
by theWestenberg test for IQR equality. However, no signiﬁcant differ-
ence was found between the two analytical approaches (p= 0.06).
The median error in OEF0 was −0.009, −0.010, 0.064 and 0.011
for the forward modelling approach, forward modelling with L2
regularisation, the Bulte analytical method and the Gauthier analytical
method. No signiﬁcant difference was found between the two forward
modelling approaches (p= 0.785), suggesting that the inclusion of L2
regularisation has not introduced any bias into the analysis. However,
a t-test revealed signiﬁcant differences (p b 0.05) between each of
the other methods, suggestive of a small bias inherent in each of the
analytical methods.
In addition to the noise modelling results, estimates from the
forward model were compared to the simulated data in a noise free
simulation. These comparisons revealed that the resting venous blood
volume could be estimated by a simple linear scaling of the calibration
parameter K. This is consistent with the Davis BOLD model (as
expressed by Eqs. (3) and (4) in Appendix A), where K is deﬁned as
A× CBV0.While the value of Awill changewith ﬁeld strength and tissue
structure, a typical value can be calculated by comparison with the
multi-compartmental BOLD model. This assignment of a constant
value to A is analogous to using ﬁxed values for α and β, which is rou-
tinely done in calibrated BOLD analysis. Computing a linear regression
of the ﬁtted value of K against the modelled venous CBV gives a value
of 3.7 for A with an R2 of 0.78.
In vivo results
In all subjects end-tidal O2 increased during periods of hyperoxia,
while end-tidal CO2 increased during hypercapnia. Fig. 5 shows an
example end-tidal recording from one subject for O2 and CO2. As
demonstrated by the traces, periods of hyperoxia appear to produce a
reduction in PETCO2, while periods of hypercapnia correspond with a
slight increase in PETO2. The average baseline PETO2 was 116 mm Hg
and the average baseline PETCO2 was 43.5 mm Hg. Plateau levels of
hyperoxia caused an increase of 240 mm Hg in PETO2. The average
change in PETCO2 from baseline was approximately 11 mm Hg.
Fig. 6 shows an example voxel-wise ﬁt for TE1 and TE2 from an
individual subject. Due to the high-pass ﬁltering of TE1 data any low
frequency information is effectively removed from the time series
(removing any baseline ﬂuctuations and BOLD contributions). Howev-
er, the presence of CBF information in TE2 is evident. It thus highlights
one of the advantages of the proposed method, in that it uses more of
the available data to determine signal changes compared to a separate
analysis of the BOLD and ASL data. BOLD and ASL signal changes in the
TE2 data are well matched to the ﬁtted data, demonstrating the
effectiveness of incorporating end-tidal traces in the ﬁtting process.
The forward modelling results (with L2 regularisation) from each
of the 10 individual subjects are shown in Table 3. As can be seen
from the table, the median grey matter parameter estimates are
within the expected physiological range for each of the subjects.
The group mean OEF0 estimate (across the subjects) is 0.39 ± 0.03,with a mean venous CBV of 2.25% ± 0.36 and a mean CMRO2 value
of 200 ± 40 μmol/100 g/min.
Fig. 7 shows scatter plots of the relationship between the measured
grey matter CBF0 and the estimated grey matter OEF0 for each subject
calculated with each analysis method (the forward model and the two
analytical methods). It is expected that the resting OEF should fall
with increasing CBF0 (Lu et al., 2008); this is clearly the case for the for-
ward modelling approach with a strong negative correlation between
the two parameters (R2 = 0.66, p b 0.05). However, no signiﬁcant cor-
relations are observed in either of the analytical approaches (p= 0.46
and 0.57). The main reason for the lack of such a relationship appears
to be the four subjects who exhibited a low resting CBF. These subjects
have high OEF0 estimates with the forward model, but low estimates
with the analytical approaches.
Table 4 shows the estimated grey matter OEF0 for each subject with
each method, and the associated coefﬁcient of variation (COV) for each
estimate, where the COV represents the voxel-wise variation over space
per subject. It is clear from the table that those subjects with the lowest
resting CBF (1, 2, 7 and 10) have unusually low estimates of OEF0 when
using either of the analytical approaches. Paired t-tests show signiﬁcant
differences in OEF0 estimates between each of the methods (p b 0.05)
apart from the two analytical methods (p = 0.21). The coefﬁcient of
variation of OEF0 estimates is signiﬁcantly (p b 0.05) reduced when
using the forward modelling approach, with an almost 2-fold reduction
in the group average COV (0.35 compared to 0.65 and 0.67). A paired
t-test also reveals that the COV for the Gauthier analytical method is
larger than for the Bulte method. However, the size of this difference
is very small.
Fig. 8 shows example OEF0 parameter maps calculated in an
individual subject with each of the analysis methods (the forward
model and the analytical approach). Consistent with the numerical
assessment, the parameter maps of OEF0 are signiﬁcantly more
uniform when calculated using the forward modelling approach.
Additionally, parameter maps calculated with the analytical
approach show several regions with areas of non-physiological
estimates (OEF less than 0 or greater than 1). As shown by the
numerical assessment, both of the analytical approaches produce
nearly identical results; therefore we have only presented parameter
maps from onemethod. The Gauthier implementation was chosen as
the noise modelling study suggests this method is less prone to
bias in OEF estimates. It should be noted that all parameter maps
show grey matter voxels with a partial volume estimate greater
than or equal to 30% (rather than the 50% threshold used in the
numerical/statistical analysis). This cut-off has been chosen to
provide a better visual assessment of parameter variation, and is
especially valuable when visualising CBV parameter maps (Fig. 9),
where estimates are expected to vary with grey matter content.
A summary image showing a single slice for each of the 10 subjects
for each of the parameters estimated by the forward model is shown
in Fig. 9. The maps demonstrate that OEF is for the most part uniform
and unrelated to grey/white matter content. However, the maps of
CMRO2, CBF and CBV show the expected grey/white matter contrast
associated with blood volume variation. Maps of CVR are generally
smooth although there are several regions of elevated (and suppressed)
CVR. It is not clear if this is physiological in nature or an SNR artefact
(CVR maps are expected to be the most affected by the limited SNR of
the ASL data).
Discussion
We have demonstrated the measurement of OEF and absolute
CMRO2 using a forward signal model and compared the performance
of the ﬁtting method to two previously proposed analytical methods.
The proposed method simultaneously estimates signal changes for TE1
and TE2 data (from a dual-echo acquisition) to ﬁnd the physiological
parameters that provide a best ﬁt to the acquired data. Because all the
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estimates is used to infer on BOLD signal changes and vice versa. Addi-
tionally, the whole time course data (for both echoes) is used in the
analysis. This is different from previously proposed methods (Bulte
et al., 2012; Gauthier et al., 2012; Wise et al., 2013), which either sepa-
rate the acquired data into plateauperiods or independently analyse the
BOLD and CBF signal changes with a GLM (or use a combination of the
two approaches).
In the proposed method a combined CBF–BOLD model is used in
combination with end-tidal recordings to simultaneously estimate all
BOLD and CBF changes from the acquired data. As with other numerical
analysis techniques, the proposed method aims to make better use of
the acquired data by considering all of the available information. In
the implementation presented here we make use of regularisation to
produce more stable estimates of the model parameters. As with any
regularisation technique there is always a trade-off to bemade between
stability and accuracy of the results. In this work we have used amodel-
ling study to determine the optimal value of the tuning parameter (λ) to
avoid unnecessarily biasing estimates of OEF (and thus CMRO2). The
forward modelling method employed here enables a variety of numer-
ical approaches to be used in tackling the minimization problem. Here
we have presented a regularized least squares approach, which is a
practical and computationally inexpensive method. However, such an
approach is limited; for example, it makes implicit assumptions about
the parameter and noise distributions. Alternatively, the problem
could be considered in Bayesian framework where the regularization
takes the form of prior distributions. Such an analysis method gives
the opportunity to deﬁne more realistic noise models, or depending
on inference method, reduce the strict distributional assumptions. If
the reader is interested in pursuing a Bayesian approach the MATLAB
code for a variational Bayes method is available http://dx.doi.org/10.
17035/d.2015.100126.
The group mean OEF value found in this study, 0.39 ± 0.03, is
similar to that found in previous dcfMRI experiments, which have
reported values of 0.35 ± 0.04 (Gauthier et al., 2012), 0.36 ± 0.05
(Germuska and Bulte, 2014), 0.38 ± 0.14 (Bulte et al., 2012),
and 0.40 ± 0.02 (Wise et al., 2013). However, previous dcfMRI
analysis methods have reported a high number of voxels with invalid
parameter estimates. For example, parameter maps presented in
(Wise et al., 2013) reveal that estimates of OEF were unreliable in
over half of the subjects for signiﬁcant proportions of grey matter
voxels. In addition, the results presented by Gauthier et al. (2012)
depict numerous regions of invalid M and OEF estimates from indi-
vidual subjects. The results presented by Bulte et al. (2012) do not
explicitly address invalid parameter estimates. However, the report-
ed individual OEF maps show large numbers of estimates close to
zero. We have employed a combination of noise modelling and
in vivo analysis to compare the stability of the proposed method
with that of those previously proposed. The modelling results
predict a signiﬁcant advantage for the proposed method with
regards to error in OEF estimates and bias. In addition, in vivo results
demonstrate an increase in stability on a voxel-wise basis, with the
proposed method being able to estimate OEF values in regions
where previous methods were shown to fail. Furthermore, the rela-
tionship between the estimated in vivo parameters shows greater
conformity to expected physiological variation with the proposed
method. For example, data analysed with the forward modelling
approach showed a strong negative correlation between resting
CBF and OEF, which was absent when the data was analysed with
previously proposed analysis methods.
Visual inspection of the estimated parameter maps also reveals
the expected variation in CBV estimates with grey matter content.
Such conﬁrmation is important as it suggests correct functioning ofFig. 9. In vivomaps of OEF, CVR, CBV, CBF and CMRO2 evaluated in a single slice for each subjec
also included for comparison.themethod at the voxel-wise level across a range of baseline physiology
(in addition to the global correlations between CBF and OEF). Previous
analysis methods have not always demonstrated this feature. For
example, dcfMRI data analysed by Wise et al. (2013) reported maps
of M that had a uniform appearance, rather than displaying the
expected CBV modulation; while the individual OEF maps reported by
Bulte et al. (2012), Gauthier et al. (2012) showed signiﬁcant regional
variation.
The modelling undertaken to compare the analysis methods was
also employed to investigate the relationship between the simpliﬁed
BOLD models routinely used in calibrated fMRI and the compartmental
BOLDmodel used in the generation of synthetic data. It is apparent from
the Davis BOLD model that a dcfMRI experiment is sufﬁcient to deter-
mine the BOLD sensitive blood volume if the calibration factor A is
known. By comparing the generated data (venous CBV) to the results
produced with our forward model we found that A could be assigned
a value of 3.7. In practice the method is similar to that proposed by
Blockley et al., and produces similar estimates of venous CBV. The
in vivo estimates of venous CBV in this work have a group mean grey
matter value of 2.25 ± 0.36% and show the expected variation with
grey matter content. These results are comparable to those reported in
Blockley et al. (2013) 2.18%, An and Lin (2002) 2.46% and He and
Yablonskiy (2007) 1.75%.
While the validity of the proposed method has been explored
with modelling studies (and tested in vivo), one source of error,
arising from the end-tidal traces, was not explicitly investigated.
All of the BOLD models used in the analysis are developed from
steady-state considerations and have not been fully explored for
dynamic signal changes. In our design we have tried to minimise
any contribution from this potential source of error by employing
pre-emphasis to reduce the transition time between states. We
expect such measures, as well as a tightly controlled experiment, to
minimise these effects. However, care should be taken when
employing these analysis methods when such fast transitions, or
stable states, cannot be achieved.
In this paper we have developed a new analysis framework
for dcfMRI. The proposed framework has been tested with noise
modelling studies and in vivo acquisitions in healthy volunteers.
The results from the in vivo analysis agree well with the expected
physiology and demonstrate the improvements predicted by the
modelling. The stability and reliability of the physiological estimates
appear to be a signiﬁcant improvement on existing techniques.
We hope that these contributions will help move this emerging
technique from a strictly research tool towards a clinically viable
method capable of measuring resting OEF, CBV, CVR, and CMRO2
from a single scanning session.
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Appendix A
A.1. Signal models
A composite signal model is constructed by combining a detailed
arterial spin labelling (ASL) model (Woolrich et al., 2006) and at using the forward modelling approach. Maps of greymatter partial volume estimates are
322 M. Germuska et al. / NeuroImage 139 (2016) 313–323simpliﬁed BOLDmodel (Wise et al., 2013). The ASL model is deﬁned for
a PASL QUIPSS II acquisition scheme (as is routinely used for ASL data
acquisition at our institution). The BOLD model extends that proposed
by Davis et al. (1998) and Hoge et al. (1999) to allow for simultaneous
changes in both oxygen content and cerebral blood ﬂow. This generali-
sation of themodel allows the complete BOLD time series to be estimat-
ed for arbitrary levels of arterial oxygen content and alterations in CBF
(provided isometabolic conditions can be reasonably assumed). The
two models (ASL and BOLD) are combined, as described by Eq. (1),
where the BOLD contribution is incorporated via a change in the
transverse relaxation rate (ΔR2⁎).
pn ¼ Sn  e−TE R

2;0 1þR2;n=R2;0ð Þ ð1Þ
where pn is the MR signal for n=1 to N acquisitions, Sn is the magneti-
zation in a voxel, R2,0⁎ is the baseline R2⁎, ΔR2,n⁎ is the change in R2⁎ for
each acquisition, and TE is the echo time.
So that the BOLD signal model can be more easily incorporated into
theASLmodel it is expressed in terms of change in transverse relaxation
rate (R2*), rather than the more common usage of change in signal
magnitude, as shown below.
A.1.1. BOLD signal model
The contribution to the transverse relaxation rate due to deoxy-
haemoglobin can be expressed as (Boxerman et al., 1995; Ogawa
et al., 1993)
R2jdHb ¼ A ∙ CBV ∙ dHb½ β ð2Þ
where [dHb] is the deoxy-haemoglobin concentration, CBV is the BOLD
sensitive blood volume, and A and β are scaling factors dependent on
the vessel geometry and ﬁeld strength. The change in relaxation rate
at non-baseline values of CBV and deoxy-haemoglobin concentration
can be expressed as
ΔR2 ¼ A∙ CBV ∙ dHb½ β− CBV0∙ dHb½ β0
h i
ð3Þ
where the subscript 0 represents the baseline value.
Rearranging Eq. (3) and exploiting the Grubb ﬂow–volume relation-
ship (Grubb et al., 1974) we get the following expression (which
describes the change in transverse relaxation rate due to a change in
blood ﬂow and/or blood saturation):
ΔR2 ¼ K ∙ dHb½ β0
CBF
CBF0
 α dHb½ 
dHb½ 0
 β
− 1
" #
ð4Þ
where α and β are assigned literature values (0.14 and 0.91 (Griffeth
and Buxton, 2011)), K=A ∙CBV0, [dHb]0=[Hb] ∙OEF0.
We are able to incorporate recordings of PETCO2 into Eq. (4) by
substituting the fractional change in blood ﬂow for the relative cerebro-
vascular reactivity (CVR). This has two advantages; ﬁrst it makes use of
all the available information (incorporating the end-tidal recordings),
second it allows parameter regularisation to be used that is not depen-
dent on the experimental design (e.g. levels of CO2 used as a stimulus).
Thus Eq. (4) can be re-written as:
ΔR2 ¼ K ∙ dHb½ β0 1þ
CVR ∙ΔPaCO2
100
 α dHb½ 
dHb½ 0
 β
− 1
" #
ð5Þ
where CVR is the ﬂow response to CO2 in %ΔCBF/mmHg and ΔPaCO2 is
the change in end-tidal CO2 from baseline in mm Hg.The fractional change in deoxy-haemoglobin concentration can be
expressed as follows (Wise et al., 2013), where again the change in
CBF has been substituted for CVR.
dHb½ 
dHb½ 0
¼ 1
1þ CVR  ΔPaCO2
100
 
−
1
dHb½ 
1
φ
CaO2 −
CaO2;0
1þ CVR  ΔPaCO2
100
 
0
BB@
1
CCA
8><
>:
þ Hb½  1
1þ CVR  ΔPaCO2
100
 −1
0
BB@
1
CCA
9>=
>;
ð6Þ
where CaO2 is the arterial oxygen content, which can be calculated from
the end-tidal oxygen recordings.
As in previous dcfMRI studies (Bulte et al., 2012; Gauthier et al.,
2012) the parameters α and β are assigned ﬁxed values and assumed
to remain constant throughout the acquisition period. Although K is
not assigned a ﬁxed value (as it represents as scaled version of the
resting blood volume), it is assumed to remain constant during both
hypercapnic and hyperoxic stimuli.
A.1.2. ASL signal model
As perWoolrich et al. (2006) the physiological ASL model includes a
static compartment Sns and a blood compartment Snb such that the
magnetization in a voxel is considered as a combination of the two,
Sn=Sns+Snb.
The signal model for each tissue compartment is as described by
Woolrich et al. unless otherwise noted. Thus, the magnetizations from
the blood and static compartments are given by Eqs. (7) and (8)
respectively:
Sbn ¼ M0;blood  CBF0  1þ
CVR  ΔPaCO2
100
 
 TI1  Rρn þ 1− Rð Þð Þ½ f
þ TI2 − TI1 − δtð Þ  1− e− TI2−TI1ð Þ=T1b þ δt
 h io ð7Þ
where M0,blood is the resting arterial blood magnetisation per unit
volume and R = Εe−TI2 /T1b. The tagging efﬁciency Ε is assumed to be
1.0 and δt is the transit delay (time between arterial tagging and the
arrival of blood in the imaging region). The alternating tag and control
conditions are represented by the term ρn, which is 1 for control
and−1 for tag.
SSn ¼ M0 1þ
ΔM
M0
 
ð8Þ
whereM0 is the baseline static magnetisation per voxel and ΔM is any
CBF induced change in the magnetization.
Changes inM0 are assumed to derive from a change in blood volume
and VASO water exchange, as described by Eq. 33 in Woolrich et al.
(2006). Thus, the hypercapnic change in Sns can be calculated from the
resting blood ﬂow (CBF0), resting total blood volume (CBVt) and the
change in blood ﬂow (using the ﬂow–volume relationship described
by Grubb et al. (1974). When simulating data all of these variables are
known, and thus the change in M0 can be simulated for a range of
physiological conditions. However, CBVt is an unknown parameter
when analysing data. Thus, we chose a pragmatic approach of using a
ﬁxed CBVt of 5% when analysing data, with the change in M0 being
estimated from the ﬂow parameters.
In an extension to the model proposed by Woolrich et al., the T1 of
blood is allowed to vary throughout the time series. This is necessary
in the context of dcfMRI to account for the T1 effects of dissolved arterial
323M. Germuska et al. / NeuroImage 139 (2016) 313–323oxygen during periods of hyperoxia. The relationship between PaO2 and
arterial blood T1 is taken to be linear and ﬁtted to the data presented in
(Ma et al., 2014), as described by Eq. (9):
T1;b ¼ b ∙ PaO2 þ c ð9Þ
where b is expressed inmmHg, and the intercept c can be related to the
normoxic T1 of blood as follows c=1.725−b ∙110. The normoxic value
at 3.0 T (1.725 s) is taken from the literature (Lu et al., 2004).
A ﬁxed value of−5 × 10−4 was used for b, extrapolating from Ma
et al. (2014), and thus a value of 1.78 for c. These values were used to
convert PaO2 to T1,b for all voxel-wise analysis (both simulated and
in vivo).
A.2. High-pass ﬁltering
The effect of slow static tissue signal changes wasminimised for TE1
and TE2 by ﬁtting to high-pass ﬁltered versions of the signals. For TE1
high-pass ﬁltering was carried out using surround subtraction,
y^ n½ TE1 ¼ y n½ TE1 − y TE1
   h n½  þ y TE1 ð10Þ
where y[n]TE1 is the acquired TE1 data, h[n]= [−1 2 – 1] / 2 and y^ [n]TE1
is the high-pass ﬁltered signal.
The high-pass ﬁlter for TE2 used a lower cut-off frequency (to
preserve the BOLD information) and was implemented to match
that provided by fslmaths (Jenkinson et al., 2012). The mean signal
for each echo time is preserved so that R2 ,0⁎ and M0 can still be
estimated. To minimise any bias introduced by the high-pass ﬁlters
the forward modelled data was processed with matching ﬁlters.
Although changes in CBF during the time series will alter the transit
delay (δt), this parameter is assigned a constant value (0.4 s). The use of
a constant transit delay in the context of QUIPSS II ASL is considered
reasonable as this acquisition scheme is designed to be insensitive to
changes in δt (Wong et al., 1998).
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